Resolute Capital Asset Partners LLC Ascendis Pharma A/S Transaction History
Resolute Capital Asset Partners LLC
- $165 Million
- Q3 2025
A detailed history of Resolute Capital Asset Partners LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Resolute Capital Asset Partners LLC holds 165,672 shares of ASND stock, worth $33.9 Million. This represents 20.02% of its overall portfolio holdings.
Number of Shares
165,672
Previous 160,672
3.11%
Holding current value
$33.9 Million
Previous $27.7 Million
18.77%
% of portfolio
20.02%
Previous 15.61%
Shares
10 transactions
Others Institutions Holding ASND
# of Institutions
315Shares Held
65.2MCall Options Held
476KPut Options Held
142K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.1 Billion35.1% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.26MShares$1.08 Billion4.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.11MShares$1.04 Billion13.88% of portfolio
-
Janus Henderson Group PLC London, X04.32MShares$884 Million0.41% of portfolio
-
Lombard Odier Asset Management (Europe) LTD London, X04.27MShares$873 Million0.89% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $11.4B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...